4.4 Article

The design of compounds with desirable properties - The anti-HIV case study

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19

Md. Oliullah Rafi et al.

Summary: This study investigates the use of structural analogues of lopinavir and favipiravir as potential anti-viral drugs against COVID-19. The researchers found that the modified analogues showed favorable binding affinity and druggable properties when interacting with the active site residues of the main protease and RNA-dependent RNA polymerase. Molecular dynamics simulation and MMPBSA analysis confirmed the high binding affinity of one lopinavir analogue towards the main protease. This study presents a new approach to identify leads for novel anti-viral drugs against COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Biochemistry & Molecular Biology

A new glimpse on the active site of SARS-CoV-2 3CLpro, coupled with drug repurposing study

Jurica Novak et al.

Summary: This study analyzed the structure and catalytic mechanism of the main protease 3CLpro in COVID-19. A machine learning model was used to conduct drug repurposing research, and several existing drugs were found to have potential inhibitory effects on this protease.

MOLECULAR DIVERSITY (2022)

Article Biochemistry & Molecular Biology

Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking

Jurica Novak et al.

Summary: The study identified a more favorable allosteric binding site on the SARS-CoV-2 3CL protease, which could be a better target for non-covalent inhibitors to prevent dimerization and activation. The tyrosine kinase inhibitors radotinib and nilotinib, used for leukemia treatment, showed potential binding to this allosteric site, as confirmed by molecular dynamics simulations.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Multidisciplinary Sciences

Withasomniferol C, a new potential SARS-CoV-2 main protease inhibitor from the Withania somnifera plant proposed by in silico approaches

Shivananada Kandagalla et al.

Summary: The study explores the potential of Withania somnifera (WS) compounds in inhibiting the SARS-CoV-2 main protease. The findings suggest that exploring effective components in herbal medicine could be a promising strategy in combating the current global health crisis.

PEERJ (2022)

Article Biochemistry & Molecular Biology

Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study

Iruthayaraj Ancy et al.

Summary: The study focused on repurposing two clinical trial drugs, TMB607 and TMC310911, as inhibitors of the SARS-CoV-2 main protease. Using molecular docking, molecular dynamics simulations, and binding free energy calculations, it was found that TMB607 forms strong interactions with the M-pro enzyme, indicating its potential for drug repurposing in the fight against COVID-19.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Chemistry, Medicinal

Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product database

Jurica Novak et al.

Summary: Through virtual screening and molecular dynamics simulations, this study identified eight molecules with potential inhibitory properties, possessing appropriate ADMET characteristics. The study demonstrates that these ligands can bind not only at the catalytic site of the enzyme, but also at crucial binding sites.

FUTURE MEDICINAL CHEMISTRY (2021)

Article Biology

Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents

Vicky Mody et al.

Summary: The study identified potential drugs that target the pivotal protease 3-chymotrypsin like protease (3CLpro) for SARS-CoV-2 replication. Some of these drugs showed inhibitory effects on the enzyme activity, suggesting they could be useful in inhibiting SARS-CoV-2 replication.

COMMUNICATIONS BIOLOGY (2021)

Article Chemistry, Physical

Molecular modeling evaluation of the binding effect of five protease inhibitors to COVID-19 main protease

Jian Liu et al.

Summary: This study investigated the binding mechanisms of several protease inhibitors to COVID-19 M-Pro, with most drug molecules found to bind stably. Lopinavir with positive charge may be the most active against COVID-19 M-Pro based on MM/PBSA free energy calculations.

CHEMICAL PHYSICS (2021)

Article Biochemistry & Molecular Biology

PubChem in 2021: new data content and improved web interfaces

Sunghwan Kim et al.

Summary: PubChem, a popular chemical information resource, has made substantial improvements in the past two years by adding data from over 100 new sources, updating its homepage and record pages, introducing new services like the Periodic Table and Pathway pages, and creating a special data collection related to COVID-19 and SARS-CoV-2 in response to the pandemic.

NUCLEIC ACIDS RESEARCH (2021)

Article Biochemical Research Methods

AntiHIV-Pred: web-resource for in silico prediction of anti-HIV/AIDS activity

Leonid Stolbov et al.

BIOINFORMATICS (2020)

Article Chemistry, Medicinal

Novel radial distribution function approach in the study of point mutations: the HIV-1 protease case study

Jurica Novak et al.

FUTURE MEDICINAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Article Chemistry, Multidisciplinary

Anti-HIV drug repurposing against SARS-CoV-2

Peng Sang et al.

RSC ADVANCES (2020)

Article Medicine, Research & Experimental

Multiple Machine Learning Comparisons of HIV Cell-based and Reverse Transcriptase Data Sets

Kimberley M. Zorn et al.

MOLECULAR PHARMACEUTICS (2019)

Article Energy & Fuels

Quantum theory of atoms in molecules for photovoltaics

Vladimir Potemkin et al.

SOLAR ENERGY (2019)

Review Pharmacology & Pharmacy

Artificial intelligence in drug development: present status and future prospects

Kit-Kay Mak et al.

DRUG DISCOVERY TODAY (2019)

Article Biochemistry & Molecular Biology

DrugBank 5.0: a major update to the DrugBank database for 2018

David S. Wishart et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Biochemistry & Molecular Biology

Grid-Based Technologies for In Silico Screening and Drug Design

Vladimir Potemkin et al.

CURRENT MEDICINAL CHEMISTRY (2018)

Review Pharmacology & Pharmacy

Machine learning in chemoinformatics and drug discovery

Yu-Chen Lo et al.

DRUG DISCOVERY TODAY (2018)

Article Chemistry, Medicinal

A Machine Learning Approach for Predicting HIV Reverse Transcriptase Mutation Susceptibility of Biologically Active Compounds

Thomas M. Kaiser et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)

Article Chemistry, Physical

Electron-based descriptors in the study of physicochemical properties of compounds

Vladimir Potemkin et al.

COMPUTATIONAL AND THEORETICAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Exploring molecular mechanism of allosteric inhibitor to relieve drug resistance of multiple mutations in HIV-1 protease by enhanced conformational sampling

Jianzhong Chen et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2018)

Review Chemistry, Medicinal

Internet Resources for Drug Discovery and Design

Vladimir Potemkin et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)

Article Chemistry, Multidisciplinary

A prediction approach for anti-HIV activity of HEPT compounds using random forest technique

Krit Inthajak et al.

MONATSHEFTE FUR CHEMIE (2017)

Article Chemistry, Medicinal

Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends

Peng Zhan et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Computational Prediction of HIV-1 Resistance to Protease Inhibitors

Ali Hosseini et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)

Article Chemistry, Medicinal

Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS

Arun K. Ghosh et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Using Hierarchical Virtual Screening To Combat Drug Resistance of the HIV-1 Protease

Nan Li et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)

Review Pharmacology & Pharmacy

Beware of docking!

Yu-Chian Chen

TRENDS IN PHARMACOLOGICAL SCIENCES (2015)

Article Biochemistry & Molecular Biology

Extremely High Mutation Rate of HIV-1 In Vivo

Jose M. Cuevas et al.

PLOS BIOLOGY (2015)

Article Chemistry, Medicinal

Developing 2D-QSAR models for naphthyridine derivatives against HIV-1 integrase activity

Mostafa Zakariazadeh et al.

MEDICINAL CHEMISTRY RESEARCH (2015)

Review Infectious Diseases

HIV protease inhibitors: a review of molecular selectivity and toxicity

Zhengtong Lv et al.

HIV AIDS-RESEARCH AND PALLIATIVE CARE (2015)

Review Pharmacology & Pharmacy

Anti-HIV Drug Development Through Computational Methods

Wan-Gang Gu et al.

AAPS JOURNAL (2014)

Article Medicine, General & Internal

HIV infection: epidemiology, pathogenesis, treatment, and prevention

Gary Maartens et al.

LANCET (2014)

Article Chemistry, Medicinal

Prediction of bioactivity of HIV-1 integrase ST inhibitors by multilinear regression analysis and support vector machine

Shouyi Xuan et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Article Chemistry, Medicinal

Assessing Molecular Docking Tools for Relative Biological Activity Prediction: A Case Study of Triazole HIV-1 NNRTIs

Tomasz Fraczek et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)

Article Biochemistry & Molecular Biology

A ligand-based approach for the in silico discovery of multi-target inhibitors for proteins associated with HIV infection

Alejandro Speck-Planche et al.

MOLECULAR BIOSYSTEMS (2012)

Article Chemistry, Medicinal

Extended-Connectivity Fingerprints

David Rogers et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)

Article Chemistry, Medicinal

Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach

V. Ravichandran et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)

Article Chemistry, Medicinal

Technique for Energy Decomposition in the Study of Receptor-Ligand Complexes

Vladimir A. Potemkin et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)

Article Chemistry, Multidisciplinary

AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility

Garrett M. Morris et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)

Article Biochemistry & Molecular Biology

A poke in the eye: Inhibiting HIV-1 protease through its flap-recognition pocket

Kelly L. Damm et al.

BIOPOLYMERS (2008)

Review Pharmacology & Pharmacy

Principles for 3D/4D QSAR classification of drugs

Vladimir Potemkin et al.

DRUG DISCOVERY TODAY (2008)

Article Biochemistry & Molecular Biology

PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations

TJ Dolinsky et al.

NUCLEIC ACIDS RESEARCH (2004)

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

The Protein Data Bank

HM Berman et al.

NUCLEIC ACIDS RESEARCH (2000)